Product & Service News
Covid 19 impact on Stago’s range
As part of our commitment to healthcare, Stago has been closely monitoring the development of Covid 19 worldwide, implementing several actions in the past few weeks. On March 11th 2020, the WHO characterized COVID-19 as a...
Read more
My Expert QC, a new web application for comparing internal quality controls
Following on from its internal and external quality controls (My Daily QC and My Qualiris QC, respectively), Stago has supplemented its quality control offer by launching My Expert QC, a connected platform dedicated solely to the...
Read more
Health Economics Outcomes evaluation of Stago D-dimer
Improved patient outcomes and experience, shorter length of stay and cost effectiveness drive the recognition of value in today’s rapidly-evolving and competitive healthcare environment.
Read more
Stago Launches Fully Automated STA®-ECA II Assay for Dabigatran (Pradaxa®) Measurement
November 3, 2015, Parsippany, NJ, USA – Diagnostica Stago, Inc. expands its offering for measurement of direct oral anticoagulants (DOACs) with the launch of its next generation ecarin-based chromogenic assay for dabigatran,...
Read more
Stago Offers the Only Commercially Available Monoclonal Antibodies Anti-Human GPVI
2014/09/25: Glycoprotein VI (GPVI), a major collagen receptor playing a crucial role in collagen-induced platelet activation and aggregation, is a ~62-kDA type 1 transmembrane receptor belonging to the immunoglobulin superfamily.
Read more